Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06175026 · ClinicalTrials.gov registry record · NA
Encouraging Healthy and Sustainable Dietary Substitutions
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 1,753
- Enrollment target
NCT06175026: Completed NA study, sponsored by Stanford University.
NCT06175026 is a NA study that has completed, run by Stanford University. The registered enrollment target is 1,753 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (25% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06175026, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,753 participants
- Enrollment target
Study Summary
The aim of this study is to examine emerging adults' responses to dietary substitution messages about health, the environment, or both health and the environment.
Primary Outcome
Participants will rate each message on perceived message effectiveness (PME) for encouraging participants to make the target dietary substitution. PME will be assessed with 4 items \[the text shown in brackets will be tailored to each substitution\]: 1. How much does this message discourage you from wanting to \[eat beef and pork / drink juice / drink cow's milk / drink sugary drinks\]? 2. How much does this message make \[eating beef and pork, etc.\] seem unpleasant to you? 3. How much does th
Interventions
- BEHAVIORAL Health messages
- BEHAVIORAL Environmental messages
- BEHAVIORAL Health and environmental messages
- BEHAVIORAL Neutral messages
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,753 participants |
| Start Date | 2024-01-22 |
| Est. Completion | 2024-02-02 |
| Phase | NA |
What the finished NCT06175026 record still lists
NCT06175026 is an interventional study that assigns participants to a tested intervention. Its 1,753 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (25% higher).
The record links to 0 conditions, and to 4 interventions - of which Health messages is the first listed.
NCT06175026 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06175026 about?
NCT06175026 is a clinical study titled "Encouraging Healthy and Sustainable Dietary Substitutions". The aim of this study is to examine emerging adults' responses to dietary substitution messages about health, the environment, or both health and the environment.
What is the current status of trial NCT06175026?
This trial is currently completed. It is a NA study. The enrollment target is 1,753 participants. The study started on 2024-01-22. Estimated completion is 2024-02-02.
What interventions are being tested in trial NCT06175026?
The interventions under investigation include: Health messages (BEHAVIORAL), Environmental messages (BEHAVIORAL), Health and environmental messages (BEHAVIORAL), Neutral messages (BEHAVIORAL).
Who is sponsoring clinical trial NCT06175026?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06175026's enrollment target sits among peer trials
1,753 61st of 2000 higher than 1,940 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07062172 · 1,753 participants · NA
Lung Cancer Screening of Family Members of Patients With Mutation-Driven Lung Cancer
- NCT06872892 · 1,755 participants · Phase 3
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
- NCT05934487 · 1,750 participants · NA
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- NCT06954337 · 1,750 participants · NA
MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI